Description of the blood test:

The Varicella-Zoster Virus (VZV) IgM test is a laboratory study used to identify an active or very recent infection caused by the VZV virus. While IgG antibodies show long-term immunity, IgM antibodies are the “first responders” produced by the immune system. Their presence typically indicates either a primary infection (chickenpox) or a reactivation of the dormant virus (shingles/herpes zoster). This test is a critical diagnostic tool for confirming the viral nature of a painful skin rash or neurological symptoms, allowing the physician to start antiviral therapy at the most effective time.

What does the analysis represent?

• Purpose: Qualitative detection of IgM class antibodies to the Varicella-Zoster virus in blood serum.
• Primary application: Diagnosis of acute chickenpox, confirmation of shingles (herpes zoster) reactivation, and investigation of VZV-related neurological complications.
• Performance: High-sensitivity enzyme immunoassay (ELISA) of a venous blood sample.

Recommendations for the test (General)

• Time: Blood collection is recommended in the morning.
• Fasting: A food intake pause of 4–8 hours is preferred.
• Rest: Spend 15–20 minutes in a calm state before the procedure.
• Important: IgM antibodies usually appear within the first few days of the rash. If tested too early, the result may be negative, requiring a repeat test after a few days.

What can affect the results?

• Cross-reactivity: Other viruses in the herpes family (like HSV-1 or HSV-2) can sometimes cause a non-specific rise in VZV IgM.
• Reactivation levels: In some cases of shingles reactivation, IgM levels may be lower than during the initial childhood chickenpox infection.

When to take the test?

• Recommendations: Prescribed for patients with a painful, blistering rash (usually following a nerve path), unexplained nerve pain (neuralgia), or sudden fever with skin lesions.
• Preparation: Standard preparation for serological tests; avoid alcohol 24 hours prior.

How to interpret the results?

How to interpret the results? The interpretation of data is the exclusive responsibility of an infectious disease specialist or a neurologist. A positive VZV IgM result is a biochemical indicator of an active viral process but is not a standalone diagnosis of the disease’s clinical course. The physician correlates this marker with the location of the rash and the presence of neurological signs. Only an expert can determine the appropriate dose of antiviral medication and assess the risk of post-herpetic neuralgia or other complications.

Possible further investigations

• VZV PCR: For direct detection of the virus DNA from the fluid of the skin vesicles (the most accurate method for active lesions).
• VZV IgG: To check if the body has also developed or already possesses long-term immunity.
• Consultation with a Neurologist: To manage acute pain and prevent chronic post-herpetic neuralgia.
• Complete Blood Count (CBC): To monitor the body’s overall response to the viral infection.

When does the next step make sense?

When does the next step make sense? A positive result for VZV IgM indicates that the virus is currently active in your system. The next step is an immediate consultation with a specialist to initiate treatment that can reduce the duration of the rash, minimize pain, and significantly lower the risk of long-term nerve damage.

👉 If necessary, you can discuss the test results with our specialized — neurologist (Doctors – TAMC).